4.6 Review

Summary of the OA biomarkers workshop 2010-genetics and genomics: new targets in OA

期刊

OSTEOARTHRITIS AND CARTILAGE
卷 19, 期 9, 页码 1091-1094

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.joca.2011.06.002

关键词

Biomarkers; Genetics; Epigenetics; Genomics

资金

  1. National Institute of Arthritis
  2. Musculoskeletal and Skin Diseases
  3. Arthritis Foundation
  4. OARSI
  5. Amgen
  6. Genzyme
  7. American Orthopaedic Society for Sports Medicine
  8. Pfizer

向作者/读者索取更多资源

On November fourth and fifth 2010 a group of more than 100 international investigators gathered in Atlanta for the second Osteoarthritis (OA) Biomarkers Global Initiative workshop titled Genetics and Genomics: New Targets in OA. The first workshop took place in April 2009 and focused on in vitro (soluble) biomarkers whilst the third and final workshop will take place in 2012 and will focus on imaging biomarkers. The OA Research Society International (OARSI) has organized the workshops. In addition to OARS!, the National Institute of Arthritis, Musculoskeletal and Skin Diseases, the Arthritis Foundation, Amgen, Genzyme, the American Orthopaedic Society for Sports Medicine and Pfizer sponsored the second meeting. It was clear from this meeting that experiments in the genetics, epigenetics and genomics of OA, are yielding valuable insights into the etiology of this heterogeneous disease but that much still needs to be learnt. Combining genetic insights with conventional biomarkers and imaging modalities may provide scientists with the enhanced tools to understand this complex disease. With those tools in hand, clinicians and industry can develop protocols to ultimately improve patient care. (C) 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Orthopedics

Genetics of osteoarthritis

G. Aubourg, S. J. Rice, P. Bruce-Wootton, J. Loughlin

Summary: Osteoarthritis genetics has made significant progress through large-scale genome-wide association scans. Over 100 genetic risk variants associated with osteoarthritis have been identified, accounting for more than 20% of its heritability. These variants are mainly located in non-protein coding regions of the genome and regulate the expression of target genes. Epigenetic factors, particularly cartilage DNA methylation changes, are also correlated with some of these variants, suggesting a potential mediation of genetic effects on gene expression.

OSTEOARTHRITIS AND CARTILAGE (2022)

Article Rheumatology

The role of TNFRSF11B in development of osteoarthritic cartilage

Alejandro Rodriguez Ruiz, Margo Tuerlings, Ankita Das, Rodrigo Coutinho de Almeida, H. Eka D. Suchiman, Rob G. H. H. Nelissen, Yolande F. M. Ramos, Ingrid Meulenbelt

Summary: This study determined the role of TNFRSF11B overexpression in the development of OA and found that it may act as a direct driving factor for the transition of chondrocytes to osteoblasts in lesioned OA cartilage, independent of the OPG/RANK/RANKL pathway commonly seen in bone remodeling.

RHEUMATOLOGY (2022)

Review Biochemistry & Molecular Biology

Translating osteoarthritis genetics research: challenging times ahead

John Loughlin

Summary: The ultimate goal of molecular genetic studies of human diseases is to benefit patients through translation of discoveries. The lack of licensed disease-modifying therapies for diseases like osteoarthritis (OA) creates an urgent need. OA is a polygenic disease that primarily affects older individuals, and recent genome-wide studies have identified 52 novel association signals. Many of these signals involve effector genes that encode proteins targeted by drugs for other indications, indicating potential repurposing opportunities. This article discusses the potential for translating OA genetic data and whether the developmental origin of OA may limit its use for disease modification.

TRENDS IN MOLECULAR MEDICINE (2022)

Article Orthopedics

ANP32A represses Wnt signaling across tissues thereby protecting against osteoarthritis and heart disease

S. Monteagudo, F. M. F. Cornelis, X. Wang, A. de Roover, T. Peeters, J. Quintiens, A. Sermon, R. C. de Almeida, I Meulenbelt, R. J. Lories

Summary: ANP32A is identified as a novel repressor of Wnt signaling in articular cartilage, and its loss leads to hyper-activation of Wnt signaling. ANP32A inhibits target gene expression by histone acetylation masking. The study also reveals the involvement of ANP32A in cardiac hypertrophy. These findings have significant implications for understanding the pathogenesis of osteoarthritis and cardiac diseases.

OSTEOARTHRITIS AND CARTILAGE (2022)

Article Rheumatology

Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohort

Eefje M. van Helvoort, Mylene P. Jansen, Anne C. A. Marijnissen, Margreet Kloppenburg, Francisco J. Blanco, Ida K. Haugen, Francis Berenbaum, Anne-Christine C. Bay-Jensen, Christoph Ladel, Agnes Lalande, Jonathan Larkin, John Loughlin, Ali Mobasheri, Harrie H. Weinans, Pawel Widera, Jaume Bacardit, Paco M. J. Welsing, Floris P. J. G. Lafeber

Summary: The IMI-APPROACH knee osteoarthritis study used machine learning to predict structural and pain progression. The study found that the predicted-progression scores were able to somewhat distinguish between actual progressors and non-progressors, with better prediction for pain progression than for structural progression.

RHEUMATOLOGY (2022)

Editorial Material Rheumatology

Toward Precision Medicine-Is Genetic Risk Prediction Ready for Prime Time in Osteoarthritis?

Michelle S. Yau, John Loughlin

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the child health and nutrition research initiative method

Zoe Paskins, Clare E. Farmer, Fay Manning, David A. Andersson, Tim Barlow, Felicity L. Bishop, Christopher A. Brown, Amanda Clark, Emma M. Clark, Debra Dulake, Malvika Gulati, Christine L. Le Maitre, Richard K. Jones, John Loughlin, Deborah J. Mason, Maura McCarron, Neil L. Millar, Hemant Pandit, George Peat, Stephen M. Richardson, Emma J. Salt, E. Jane Taylor, Linda Troeberg, Ruth K. Wilcox, Elspeth Wise, Colin Wilkinson, Fiona E. Watt

Summary: Involving research users in setting research priorities is crucial for patient-centered outcomes and maximizing value and impact. This study used the Child Health and Nutrition Research Initiative (CHNRI) method to identify key research priorities for musculoskeletal disorders. The priorities included developing new treatments, improving treatment targeting, early diagnosis, prevention, and understanding and management of pain.

LANCET RHEUMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Genetic risk of osteoarthritis operates during human skeletogenesis

Sarah J. Rice, Abby Brumwell, Julia Falk, Yulia S. Kehayova, John Casement, Eleanor Parker, Ines M. J. Hofer, Colin Shepherd, John Loughlin

Summary: This study investigates the activity and impact of genetic risk factors for osteoarthritis (OA) during human skeletogenesis. It shows that OA genetic risk is present during fetal development and is associated with allelic expression imbalances of specific genes. These findings are significant for understanding the pathogenesis of OA and developing pharmacological interventions.

HUMAN MOLECULAR GENETICS (2023)

Article Rheumatology

Allelic expression imbalance in articular cartilage and subchondral bone refined genome-wide association signals in osteoarthritis

Rodrigo Coutinho de Almeida, Margo Tuerlings, Yolande Ramos, Wouter Den Hollander, Eka Suchiman, Nico Lakenberg, Rob G. H. H. Nelissen, Hailiang Mei, Ingrid Meulenbelt

Summary: This study presents an unbiased approach to identify positional transcript SNPs associated with osteoarthritis (OA) risk loci using allelic expression imbalance (AEI) analyses. By prioritizing proxy transcript SNPs that mark AEI in cartilage and/or subchondral bone at loci harbouring GWAS signals, the study identifies 10 new potential OA risk genes ready for further exploration of their underlying biological mechanisms.

RHEUMATOLOGY (2023)

Article Rheumatology

Mediation of the Same Epigenetic and Transcriptional Effect by Independent Osteoarthritis Risk-Conferring Alleles on a Shared Target Gene, COLGALT2

Yulia S. Kehayova, J. Mark Wilkinson, Sarah J. Rice, John Loughlin

Summary: This study aims to determine the target gene(s) and mechanism of action of the osteoarthritis (OA) locus. It was found that COLGALT2 is the target gene of this OA locus, and its expression is regulated by DNA methylation.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Inhibition of KDM7A/B histone demethylases restores H3K79 methylation and protects against osteoarthritis

Reem Assi, Chahrazad Cherifi, Frederique M. F. Cornelis, Qiongfei Zhou, Lies Storms, Sofia Pazmino, Rodrigo Coutinho de Almeida, Ingrid Meulenbelt, Rik J. J. Lories, Silvia Monteagudo

Summary: The methylation of H3K79me is reduced in osteoarthritis. Histone demethylase families, such as Jumonji-C and KDM2/7, can increase the levels of H3K79me and targeting KDM2/7 can protect joints against osteoarthritis.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Orthopedics

Mechanical stress and inflammation have opposite effects on Wnt signaling in human chondrocytes

Ritchie G. M. Timmermans, Arjen B. Blom, Rob G. H. H. Nelissen, Demien Broekhuis, Peter M. van der Kraan, Ingrid Meulenbelt, Martijn H. J. van den Bosch, Yolande F. M. Ramos

Summary: The dysregulation of Wnt signaling plays a key role in the development and progression of osteoarthritis (OA). This study investigates how mechanical stress (MS) and inflammation independently affect Wnt signaling in human neocartilage and its relationship to OA pathophysiology. Results show that MS and inflammatory stimuli have opposite effects on canonical and noncanonical Wnt signaling in human neocartilage.

JOURNAL OF ORTHOPAEDIC RESEARCH (2023)

Article Rheumatology

Osteoarthritis genetic risk acting on the galactosyltransferase gene COLGALT2 has opposing functional effects in articulating joint tissues

Yulia S. Kehayova, J. Mark Wilkinson, Sarah J. Rice, John Loughlin

Summary: Investigation reveals that DNA variants rs11583641 and rs1046934 decrease methylation status and increase expression of COLGALT2 in cartilage, marking risk for osteoarthritis. This study investigates if these effects are present in non-cartilaginous joint tissues.

ARTHRITIS RESEARCH & THERAPY (2023)

Article Geriatrics & Gerontology

Identified senescence endotypes in aged cartilage are reflected in the blood metabolome

Ilja Boone, Margo Tuerlings, Rodrigo Coutinho de Almeida, Johannes Lehmann, Yolande Ramos, Rob Nelissen, Eline Slagboom, Peter de Keizer, Ingrid Meulenbelt

Summary: This study characterized the heterogeneity of cellular senescence within aged articular cartilage and explored the presence of corresponding metabolic profiles in blood as representative biomarkers. Two robust cellular senescent endotypes were identified, with one enriched for cell proliferating pathways and the other enriched for inflammation-associated pathways. Corresponding metabolic clusters were found in the blood samples. These non-invasive metabolic profiles could serve as biomarkers for targeted senescence treatment in osteoarthritis patients.

GEROSCIENCE (2023)

Article Rheumatology

Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effector gene of osteoarthritis genetic risk

Abby Brumwell, Guillaume Aubourg, Juhel Hussain, Eleanor Parker, David J. Deehan, Sarah J. Rice, John Loughlin

Summary: This study investigated a genetic locus associated with osteoarthritis and identified TMEM129 as a target gene at the locus. The genotype at rs11732213 was found to impact the DNA methylation at an enhancer, which in turn modulated TMEM129 expression. This research provides new insights into the susceptibility of osteoarthritis.

ARTHRITIS RESEARCH & THERAPY (2022)

暂无数据